Those taking GLP-1 drugs also were less likely to suffer side effects like kidney damage, stomach ulcers or GI bleeding than those on aspirin, researchers said
The broader pattern of GLP-1 drugs reducing addictive and compulsive behavior has shown up across multiple datasets, including a 606,000-veteran cohort published in BMJ earlier this year showing meaningful reductions in alcohol, nicotine, and opioid use disorder rates in GLP-1 users
There are many peptide suppliers, but not all adhere to the same quality control standards
But in practice, these two compounds produce completely different outcomes, work through fundamentally different mechanisms, and carry very different risk profiles
It protects liver cells that are exposed to toxins on a daily basis